Saibal Kar

Economics and Econometrics · 2005–2019

A researcher in the Science corpus: 10 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Economics and Econometrics — 15 citations into it

Whom Saibal Kar trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. A. Laffer
2. Ramazan Gencay
3. Tianqi Chen
4. Allan G. Timmermann
5. Depei Bao

Who trusts Saibal Kar overall

1. Mojtaba Nabipour
2. Arkajyoti Saha

Papers from Saibal Kar's perspective

Ordered by how strongly the researchers Saibal Kar trusts endorse each paper. Same corpus, a different order for every researcher.

1. Greedy function approximation: A gradient boosting machine.
2. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
3. XGBoost: A Scalable Tree Boosting System
4. Bayesian data analysis.
5. Apixaban in patients with atrial fibrillation. (New England Journal of Medicine)
6. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
7. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
8. Efficient market hypothesis and forecasting
9. Intelligent stock trading system by turning point confirming and probabilistic reasoning
10. Matplotlib: A 2D Graphics Environment

Their papers

• Predicting the direction of stock market prices using tree-based classifiers (2019) — 321 citations
• Emigration and wage inequality (2005) — 139 citations
• Transcatheter Mitral‐Valve Repair in Patients with Heart Failure (2018) — 1,974 citations
• 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. (2017) — 947 citations
• Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. (2015) — 833 citations
• Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. (2014) — 1,676 citations
• Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
• Closure or medical therapy for cryptogenic stroke with patent foramen ovale. (2012) — 1,023 citations
• Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry (2011) — 889 citations
• Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. (2009) — 929 citations